Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11285129 Treatment of circadian rhythm disorders
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
July 6, 2021
0
Date of Patent
March 29, 2022
0
Patent Application Number
17368160
0
Patent Citations
US Patent 10610510 Treatment of circadian rhythm disorders
US Patent 10610511 Method of treatment
US Patent 10829465 Highly purified pharmaceutical grade tasimelteon
US Patent 10611744 Highly purified pharmaceutical grade tasimelteon
US Patent 10980770 Treatment of circadian rhythm disorders
US Patent 10071977 Highly purifid pharmaceutical grade tasimelteon
US Patent 10149829 Treatment of circadian rhythm disorders
Patent Citations Received
US Patent 11918556 Treatment of circadian rhythm disorders
0
US Patent 11850229 Treatment of circadian rhythm disorders
0
Patent Inventor Names
Marlene Michelle Dressman
0
Mihael H. Polymeropoulos
0
John Joseph Feeney
0
Louis William Licamele
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11285129
0
Patent Primary Examiner
Golam M. Shameem
0
CPC Code
A61K 9/006
0
A61K 31/343
0
Find more entities like US Patent 11285129 Treatment of circadian rhythm disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE